Kiadis Pharma recently hosted a Key Opinion Leader Lunch: Addressing the Risks of Haploidentical HSCT in Blood Cancer

The meeting featured presentations by key opinion leaders Steven Devine, MD (Ohio State University) and Denis-Claude Roy, MD (University of Montreal), who discussed the risks and limitations of haploidentical hematopoietic stem cell transplantation (HSCT) in blood cancer, specifically Graft-versus-Host-Disease (GVHD) and cancer relapse.

Read More View webcast
Investors

In this section you can find out more about our investor activities: financial calendar, presentations, shareholder information and financial reports.

DISCOVER MORE FIND OUT MORE ABOUT OUR PRIVATE PLACEMENT